No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Wells Fargo Downgrades Zymeworks(ZYME.US) to Hold Rating, Raises Target Price to $14
Wells Fargo Maintains Equal-Weight on Zymeworks, Raises Price Target to $14
Biggest Stock Movers Tuesday: ZYME, EVGO, and More
J.P. Morgan Upgrades Zymeworks(ZYME.US) to Buy Rating, Raises Target Price to $18
Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)
Express News | Zymeworks Inc : JP Morgan Raises to Overweight From Neutral; Raises Target Price to $18 From $12
Unlock the Full List